Efficacy of salvage therapies after failure of adjuvant anti-PD-1 monotherapy for melanoma in the Chinese population: a multi-institutional cohort study

The majority of melanoma patients experience relapse during adjuvant therapy or after the end of therapy. Sixty-one patients from 3 melanoma centres who experienced recurrence and received adjuvant pembrolizumab for resected stage III/IV melanoma were enrolled. Disease characteristics, recurrence ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Dong-Dong, Xu, Yu, Li, Ting, Yang, Ji-Long, Chen, Yong, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290033/
https://www.ncbi.nlm.nih.gov/pubmed/37093349
http://dx.doi.org/10.1007/s10637-023-01348-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290033/
https://www.ncbi.nlm.nih.gov/pubmed/37093349
http://dx.doi.org/10.1007/s10637-023-01348-5

Ejemplares similares